P231 - Assessing predictive factors for Disease-Free Survival (DFS) and Overall Survival (OS) in patients eligible for adjuvant immunotherapy (IO) following Radical Cystectomy (RC) for Muscle-Invasive Bladder Cancer (MIBC)

Autor: Foschi, N., Ciccarese, C., Russo, P., Marino, F., Rossi, F., Maioriello, G., Anghelone, A., Filomena, G.B., Fantasia, F., Tortora, G., Iacovelli, R.
Zdroj: In European Urology March 2024 85 Supplement 1:S320-S320
Databáze: ScienceDirect
Externí odkaz: